Mani, Inc. (TYO:7730)
1,204.00
+2.50 (0.21%)
May 21, 2025, 3:30 PM JST
Mani, Inc. Revenue
Mani, Inc. had revenue of 7.16B JPY in the quarter ending February 28, 2025, with 5.31% growth. This brings the company's revenue in the last twelve months to 29.42B, up 11.54% year-over-year. In the fiscal year ending August 31, 2024, Mani, Inc. had annual revenue of 28.51B with 16.44% growth.
Revenue (ttm)
29.42B
Revenue Growth
+11.54%
P/S Ratio
4.03
Revenue / Employee
7.08M
Employees
4,154
Market Cap
118.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 28.51B | 4.03B | 16.44% |
Aug 31, 2023 | 24.49B | 4.07B | 19.95% |
Aug 31, 2022 | 20.42B | 3.23B | 18.77% |
Aug 31, 2021 | 17.19B | 1.99B | 13.09% |
Aug 31, 2020 | 15.20B | -3.13B | -17.06% |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |